Quercetin in an animal model of spinal cord compression injury: Correlation of treatment duration with recovery of motor function

Spinal Cord

Volumn 48, Issue 2, 2010, Pages 112-117

  Schultke E ^a,b   Kamencic, H ^a   Skihar, V M ^a   Griebel, R ^b   Juurlink, B ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Animal model; BBB locomotor scale; Duration of treatment; Motor function; Quercetin

Indexed keywords

QUERCETIN;

ANIMAL TISSUE; ARTICLE; CONVALESCENCE; CORRELATION ANALYSIS; MALE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; THORACIC SPINAL CORD; THORACIC SPINE; TISSUE PRESERVATION; TREATMENT DURATION; WALKING; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EFFERENT PATHWAYS; INJECTIONS, INTRAPERITONEAL; MALE; MODELS, ANIMAL; QUERCETIN; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; SPINAL CORD COMPRESSION; TIME FACTORS; TREATMENT OUTCOME;

EID: 76649142733     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2009.111     Document Type: Article

References (17)

1. Schultke E, Kendall E, Kamencic H, Ghong Z, Griebel RW, Juurlink BHJ. Quercetin promotes recovery from acute spinal cord injury: an MRI supported efficacious dose determination. J Neurotrauma 2003; 20: 583-591.
2. Schultke E, Kamencic H, Zhao M, Tian G-F, Baker AJ, Griebel RW et al. Neuroprotection following fluid percussion brain trauma. A pilot study using quercetin. J Neurotrauma 2005; 22: 1475-1484.
3. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991; 75: 25-26.
4. Tator CH. Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol 1995; 5: 407-413.
5. Tator CH, Koyanagi I. Vascular mechanisms in the pathophysiology of human spinal cord injury. J Neurosurg 1997; 86: 483-492.
6. Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L. Acute inflammatory response in spinal cord injury following impact injury. Exp Neurol 1998; 152: 77-88.
7. Juurlink BHJ, Paterson PG. Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological interventions and nutritional management strategies. J Spinal Cord Med 1998; 21: 309-334.
8. Sekhon LHS, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 2001; 26: S2-12.
9. Pincemail J, Deby C, Thirion A, De Btuyn-Dister M, Goutier R. Human myeloperoxidase activity is inhibited in vitro by quercetin. Comparison with three related compounds. Experientia 1998; 44: 450-453.
10. Klebanoff SJ. Oxygen metabolites from phagocytes. In: Gallin JI and Snyderman R (eds). Inflammation: basic principles and clinical correlates. Lippincott Williams & Wilkins: Philadelphia, 1999, pp 721-768.
11. Rivlin AS, Tator CH. Effect of duration of acute spinal cord compression in a new acute injury model in the rat. Surg Neurol 1978; 10: 38-43.
12. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field tests in rats. J Neurotrauma 1995; 12: 1-21.
13. Basso DM, Beattie MS, Bresnahan JC, Anderson DK, Faden AI, Gruner JA et al. MASCIS evaluation of open field locomotor scores: Effects of experience and teamwork on reliability. J Neurotrauma 1996; 13: 343-359.
14. Khaled KA, El-Sayed YM, Al-Hadiya BM. Disposition of the flavonoid quercetin in rats after single intravenous and oral doses. Drug Dev Ind Pharm 2003; 29: 397-403.
15. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000; 351: 95-105.
16. Gugler R, Leschik M, Dengler HJ. Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 1975; 9: 229-234.
17. Conquer JA, Maiani G, Azzini E, Raguzzini A, Holub BJ. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J Nutr 1998; 128: 593-597